AseraCare FCA Ruling Is A Boon For Health Providers

By Chris Donovan, Lisa Noller and Lori Rubin ( January 31, 2020, 4:24 PM EST) -- All hospice providers routinely should assess risk exposure under the False Claims Act[1] — now with the benefit of the U.S. Court of Appeals for the Eleventh Circuit's long-awaited decision in United States v. AseraCare Inc.[2] There, the Eleventh Circuit sketched the contours of when a physician certification of terminal illness — and resulting certification by the facility — may be considered false under the FCA....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!